. 2008 Jul;19(7):1379–1388. doi: 10.1681/ASN.2007091002

Table 5.

Crude and adjusted HR for mortality by race/ethnicity stratified by activated vitamin D therapy

Parameter	White (HR [95% CI])	Hispanic (HR [95% CI])	Black (HR [95% CI])
Activated vitamin D use
crude HR of death	Reference	0.59 (0.46 to 0.76)^a	0.66 (0.57 to 0.76)^a
age- and gender-adjusted HR of death	Reference	0.69 (0.53 to 0.88)^a	0.89 (0.77 to 1.03)
multivariable-adjusted HR of death^b	Reference	0.72 (0.55 to 0.94)^a	0.84 (0.71 to 0.98)^a
multivariable- and facility-adjusted HR^b	Reference	0.65 (0.47 to 0.89)^a	0.73 (0.61 to 0.88)^a
No activated vitamin D use
crude HR of death	Reference	0.98 (0.74 to 1.28)	1.33 (1.08 to 1.64)^a
age- and gender-adjusted HR of death	Reference	1.10 (0.83 to 1.45)	1.65 (1.33 to 2.04)^a
multivariable-adjusted HR of death^b	Reference	0.93 (0.68 to 1.26)	1.35 (1.07 to 1.69)^a
multivariable- and facility-adjusted HR^b	Reference	0.96 (0.64 to 1.44)	1.32 (1.01 to 1.74)^a

Significant differences (P < 0.05) versus white.

Adjusted for age, gender, assigned cause of renal failure, BP, BMI, vascular access at the initiation of hemodialysis, comorbidities, SMR, laboratory tests, and urea reduction ratio.